Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Medartis Holding AG
  6. Summary
    MED   CH0386200239

MEDARTIS HOLDING AG

(MED)
  Report
Delayed Swiss Exchange  -  11:31 2022-08-17 am EDT
84.00 CHF   +4.35%
08/16Medartis Lowers FY22 Sales Outlook; H1 Profit Tanks on Nextremity Solutions Acquisition Charges
MT
08/16MEDARTIS : Press release 2022 H1 results
PU
08/16MEDARTIS : Financial Report H1 2022
PU
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
08/11/2022 08/12/2022 08/15/2022 08/16/2022 08/17/2022 Date
87.2(c) 88.4(c) 87.1(c) 80.5(c) 84(c) Last
2 208 2 064 2 993 9 992 8 297 Volume
+4.18% +1.38% -1.47% -7.58% +4.35% Change
More quotes
Estimated financial data (e)
Sales 2022 188 M 198 M 198 M
Net income 2022 1,67 M 1,75 M 1,75 M
Net cash position 2022 9,17 M 9,62 M 9,62 M
P/E ratio 2022 630x
Yield 2022 -
Sales 2023 226 M 237 M 237 M
Net income 2023 5,60 M 5,87 M 5,87 M
Net cash position 2023 6,20 M 6,50 M 6,50 M
P/E ratio 2023 162x
Yield 2023 -
Capitalization 995 M 1 044 M 1 044 M
EV / Sales 2022 5,23x
EV / Sales 2023 4,38x
Nbr of Employees 684
Free-Float 32,2%
More Financials
Company
Medartis Holding AG is a Switzerland-based holding company of the Medartis Group, which is engaged in manufacturing medical devices and implants. The Group develops, manufactures and distributes to surgeons, hospitals and medical centers titanium screws, plates, surgical instruments and system solutions for internal fracture fixation. Medartis AG, the Company's wholly-owned subsidiary, has developed such... 
Read more
More about the company
Ratings of Medartis Holding AG
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about MEDARTIS HOLDING AG
08/16Medartis Lowers FY22 Sales Outlook; H1 Profit Tanks on Nextremity Solutions Acquisition..
MT
08/16MEDARTIS : Press release 2022 H1 results
PU
08/16MEDARTIS : Financial Report H1 2022
PU
08/16MEDARTIS : Presentation half-year results 2022
PU
08/16Medartis reports 20% sales growth and makes further progress in strengthening its US or..
EQ
07/27INVITATION WEBCAST : Medartis 2022 half-year results presentation
PU
05/03Medartis Closes Nextremity Solutions Buy in $70 Million Deal
MT
05/03Medartis completes acquisition of Nextremity Solutions Inc. and announces new US leader..
EQ
05/03Medartis Holding AG completed the acquisition of Nextremity Solutions, Inc.
CI
04/08Medartis Cancels Planned Convertible Bond Placement
MT
04/08Medartis has decided not to pursue the convertible bond placement
EQ
04/08MEDARTIS : Press release Medartis not to purse convertible bond placement
PU
04/07Switzerland Medartis Targets Up To $160 Million Convertible Bond Due 2028
MT
04/07Medartis launches senior convertible bond offering with a target size of CHF 125-150 mi..
EQ
04/07MEDARTIS : Press release Medartis launches convertible bond offering
PU
More news
News in other languages on MEDARTIS HOLDING AG
08/16BOURSE ZURICH : dans le rouge, le SMI défend la barre des 11'100 points
08/16AKTIEN SCHWEIZ SCHLUSS : Schwächer - Konjunktur- und Zinssorgen dämpfen
08/16Medartis plombé par l'acquisition de Nextremity début 2022
08/16BOURSE ZURICH : le SMI ne parvient pas à remonter la pente
08/16AKTIEN SCHWEIZ : SMI im Spannungsfeld zwischen Bangen und Hoffen
More news
Analyst Recommendations on MEDARTIS HOLDING AG
More recommendations
Chart MEDARTIS HOLDING AG
Duration : Period :
Medartis Holding AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDARTIS HOLDING AG
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Last Close Price 84,00 CHF
Average target price 131,33 CHF
Spread / Average Target 56,3%
EPS Revisions
Managers and Directors
Christoph Brönnimann Chief Executive Officer
Dirk W. Kirsten Chief Financial Officer
Marco Gadola Chairman
Manuel Schaer Chief Technology Officer
Jürg Greuter Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
MEDARTIS HOLDING AG-38.17%1 003
STRYKER CORPORATION-16.18%84 804
SMITH & NEPHEW PLC-18.05%11 146
INSPIRE MEDICAL SYSTEMS, INC.-6.35%6 203
AXONICS, INC.29.20%3 554
GLAUKOS CORPORATION18.72%2 510